| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 3,875-16.66% | ₹134.45 -23.21% | 800 | ₹1.7 36% | 6,200300% |
| - | - | 840 | ₹3.2 42.22% | 4,650500% |
| 7750% | ₹131 0% | 850 | ₹4.6 9.52% | 54,25011.11% |
| - | - | 860 | ₹6 -1.63% | 20,925-6.89% |
| - | - | 870 | ₹7.65 -6.7% | 13,175142.85% |
| 1,5500% | ₹60.6 -42.17% | 880 | ₹9.65 2.11% | 60,450-21.21% |
| - | - | 890 | ₹12.15 5.19% | 26,35078.94% |
| 1,05,4008.8% | ₹45.9 -13.39% | 900 | ₹14.75 3.14% | 1,99,9508.40% |
| - | - | 910 | ₹17.35 0.57% | 20,15030% |
| 16,2750% | ₹64 0% | 920 | ₹22.1 9.4% | 60,4501.29% |
| 45,72578.78% | ₹27.95 -13.86% | 930 | ₹27 7.78% | 35,650228.57% |
| 67,42555.35% | ₹24 -17.66% | 940 | ₹31.7 8.19% | 68,20015.78% |
| 1,69,7259.5% | ₹20 -19.02% | 950 | ₹38.3 8.65% | 49,60036.17% |
| 2,69,700-4.65% | ₹16.05 -24.47% | 960 | ₹43.05 4.49% | 1,07,725-4.79% |
| 1,97,62520.28% | ₹12.6 -27.16% | 970 | ₹46.7 0.53% | 66,650-5.49% |
| 1,64,3008.16% | ₹10.1 -28.87% | 980 | ₹56.45 5.02% | 94,5500% |
| 92,2251.70% | ₹8 -31.62% | 990 | ₹41.2 -1.19% | 31,7750% |
| 4,13,850-0.18% | ₹6.55 -30.68% | 1,000 | ₹72.6 0.76% | 1,21,6750% |
| 16,275600% | ₹5.4 -25.51% | 1,010 | - | - |
| 62,775-7.95% | ₹3.95 -35.24% | 1,020 | ₹60 0% | 6,9750% |
| 6,2000% | ₹5.3 6% | 1,030 | - | - |
| 1,09,2750% | ₹2.65 -32.91% | 1,040 | - | - |
| 37,97511.36% | ₹2 -34.42% | 1,050 | - | - |
| 53,475-1.42% | ₹1.7 -34.61% | 1,060 | - | - |
| 45,725-1.66% | ₹1.4 -20% | 1,080 | - | - |
| 1,45,700-9.61% | ₹0.85 -29.16% | 1,100 | ₹135 0% | 2,3250% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.